INMB vs LHX · rev $50.0K vs P/E 34, rev $5.88B
INmune Bio Inc (INMB) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
INMB currently screens at market cap $33.5M. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the INMB and LHX stock pages for the full models.
Not investment advice.